Insider Trading & Ownership - Katz Barrett

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Katz Barrett
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-01-13
Sale
2023-01-18
5:58 pm
Viridian Therapeutics Inc.VRDNKatz Barrett
Chief Medical Officer
29,000$37.18$1,078,261558,853
(Direct)
View
2023-01-09
Sale
2023-01-11
7:09 pm
Viridian Therapeutics Inc.VRDNKatz Barrett
Chief Medical Officer
60,000$34.82$2,089,472639,377
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-02-08
Option Award
2023-02-10
4:54 pm
N/A
2033-02-08
Viridian Therapeutics Inc.VRDNKatz Barrett
Chief Medical Officer
108,000$0108,000
(Direct)
View
2023-01-13
Exercise
2023-01-18
5:58 pm
N/A
N/A
Viridian Therapeutics Inc.VRDNKatz Barrett
Chief Medical Officer
29,000$23.03558,853
(Direct)
View
2023-01-13
Exercise
2023-01-18
5:58 pm
N/A
2031-01-17
Viridian Therapeutics Inc.VRDNKatz Barrett
Chief Medical Officer
29,000$0558,853
(Direct)
View
2023-01-09
Exercise
2023-01-11
7:09 pm
N/A
N/A
Viridian Therapeutics Inc.VRDNKatz Barrett
Chief Medical Officer
60,000$23.03639,377
(Direct)
View
2023-01-09
Exercise
2023-01-11
7:09 pm
N/A
2031-01-17
Viridian Therapeutics Inc.VRDNKatz Barrett
Chief Medical Officer
60,000$0639,377
(Direct)
View
2022-02-02
Option Award
2022-02-03
6:13 pm
N/A
2032-02-02
Viridian Therapeutics Inc.VRDNKatz Barrett
Chief Medical Officer
110,000$0110,000
(Direct)
View
2021-01-18
Option Award
2021-01-21
7:33 pm
N/A
2031-01-17
Viridian Therapeutics Inc.VRDNKatz Barrett
Chief Medical Officer
356,000$0356,000
(Direct)
View